ID
45006
Beschrijving
Principal Investigator: Eric Lander, Broad Institute, Cambridge, MA, USA MeSH: Congenital Abnormalities,Bardet-Biedl Syndrome,Orofaciodigital Syndromes https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000288 The study is aimed at identifying new genes involved in pediatric brain disorders from inbred families originating predominantly in the Middle East. Each patient analyzed to date has a specific and highly unique neurodevelopmental disorder that is likely to be recessive in nature. Many patients have one of the diseases along the "ciliopathy" spectrum of diseases, with evidence of kidney failure, retinal blindness and cerebellar ataxia.
Link
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000288
Trefwoorden
Versies (2)
- 04-07-22 04-07-22 - Chiara Middel
- 12-10-22 12-10-22 - Adrian Schulz
Houder van rechten
Eric Lander, Broad Institute, Cambridge, MA, USA
Geüploaded op
4 juli 2022
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs000288 Ciliopathies Exome Sequencing Initiative
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with or without ciliopathies and involved in the "Ciliopathies Exome Sequencing Initiative" project.
- Family ID, subject ID, mother ID, father ID, sex, and twin ID of participants with or without ciliopathies and involved in the "Ciliopathies Exome Sequencing Initiative" project.
- Subject ID, sample ID, and sample use variable obtained from participants with or without ciliopathies and involved in the "Ciliopathies Exome Sequencing Initiative" project.
- Subject ID, age, gender, and ethnicity of participants with or without ciliopathies and involved in the "Ciliopathies Exome Sequencing Initiative" project.
- Sample ID, body site where sample was obtained, analyte type, histological type of sample, and tumor status of samples of participants with or without ciliopathies and involved in the "Ciliopathies Exome Sequencing Initiative" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with or without ciliopathies and involved in the "Ciliopathies Exome Sequencing Initiative" project.
- Family ID, subject ID, mother ID, father ID, sex, and twin ID of participants with or without ciliopathies and involved in the "Ciliopathies Exome Sequencing Initiative" project.
- Subject ID, sample ID, and sample use variable obtained from participants with or without ciliopathies and involved in the "Ciliopathies Exome Sequencing Initiative" project.
- Subject ID, age, gender, and ethnicity of participants with or without ciliopathies and involved in the "Ciliopathies Exome Sequencing Initiative" project.
- Sample ID, body site where sample was obtained, analyte type, histological type of sample, and tumor status of samples of participants with or without ciliopathies and involved in the "Ciliopathies Exome Sequencing Initiative" project.
C0680251 (UMLS CUI [1,2])
C1517194 (UMLS CUI [1,2])
C1519210 (UMLS CUI [1,3])
C3844700 (UMLS CUI [2,1])
C0086282 (UMLS CUI [2,2])
C0522476 (UMLS CUI [2,3])
C0017337 (UMLS CUI [1,2])
C3899368 (UMLS CUI [1,3])
C2828389 (UMLS CUI [2,1])
C0017337 (UMLS CUI [2,2])
C1708726 (UMLS CUI [2,3])
C1265611 (UMLS CUI [1,2])
C3272453 (UMLS CUI [1,3])
C0332306 (UMLS CUI [1,2])
C0012854 (UMLS CUI [1,3])
C0012854 (UMLS CUI [2,1])
C2349182 (UMLS CUI [2,2])
C0017393 (UMLS CUI [2,3])
C0079399 (UMLS CUI [2,4])
C0012854 (UMLS CUI [3,1])
C2349182 (UMLS CUI [3,2])
C0728826 (UMLS CUI [3,3])
C0796346 (UMLS CUI [3,4])
C0023745 (UMLS CUI [1,2])
C3702387 (UMLS CUI [1,3])